Octavio Espinoza

Chief Financial Officer, Ligand Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$13.0M

Companies

Latest trade

Aug 12, 2026

Companies

Ligand PharmaceuticalsChief Financial Officer −$13.0M

Trades

LGND Sold 31,641 shares at $292.07 · planned $9.2M Aug 12

LGND Sold 3,057 shares at $225.00 · planned $0.7M Mar 11

LGND Sold 13,423 shares at $205.83 · planned $2.8M Mar 4

LGND Sold 1,804 shares at $188.31 $0.3M Dec 12

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.